When chronic conditions, persistent joint pain, or inflammatory disorders have not responded to conventional treatments available in Singapore, mesenchymal stem cell therapy offers a regenerative alternative. Advanced MSC protocols are restricted under HSA regulations, limiting domestic access for Singaporean patients. Our Chiang Mai clinic, under three hours from Changi, provides quality-controlled stem cell therapy with Mandarin-speaking clinical support and coordination with your Singapore medical team.
Mesenchymal stem cell (MSC) therapy uses laboratory-expanded stem cells to target tissue damage, reduce chronic inflammation, and promote cellular repair. Cells are quality-tested and delivered under imaging guidance to ensure precise targeting of affected areas. The treatment process involves initial assessment, cell preparation by our laboratory team, and image-guided delivery to the treatment site. For a comprehensive understanding of the science, evidence, and treatment process, visit our full Stem Cell Therapy page.
Singaporean patients value the quality-controlled MSC protocols, the structured clinical governance, and the significant cost difference compared to the limited domestic options available. Each stem cell programme is individually designed based on diagnostic assessment and treatment goals rather than a one-size-fits-all approach. Mandarin-speaking clinical staff ensure that patients fully understand the treatment process, expected outcomes, and follow-up requirements. Comprehensive treatment records are provided for your Singapore GP or specialist to support ongoing care.
Yes. Thailand has a regulatory framework that permits stem cell therapy under proper medical supervision and quality standards.
Typically five to seven days in Chiang Mai.
Yes. Many Singapore patients combine stem cell therapy with anti-ageing or exosome protocols.
Structured video consultations at scheduled intervals after returning to Singapore.
Costs vary by protocol. Treatment in Thailand is significantly more affordable than comparable options internationally.
Yes. Comprehensive treatment summaries are provided for your local physician.
Singapore's HSA regulates stem cell treatments under the Cell, Tissue and Gene Therapy Products (CTGTP) framework, which requires extensive clinical trial data and product registration before treatments can be offered commercially. This limits access to many mesenchymal stem cell protocols that are available in Thailand.
We use mesenchymal stem cells (MSCs) sourced from ethically obtained, quality-controlled tissue. The specific cell type and source are selected based on your medical assessment and treatment goals.
Yes. Thailand has an established regulatory framework for stem cell therapy. Our protocols follow international standards with comprehensive pre-treatment screening, quality-controlled cell processing, and structured follow-up monitoring.